Open AccessEXPERIENCE WITH IBRUTINIB IN PATIENTS WITH REFRACTORY AND RECURRENT B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Author(s) -
В. Г. Сорокина,
Р. Горячева,
А. Спирина,
С. Аль-Ради,
N.V. Obukhova,
В. Бидерман,
Н. С. Моисеева
Publication year - 2017
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2017-6-132-138
Subject(s) - ibrutinib , medicine , refractory (planetary science) , chronic lymphocytic leukemia , salvage therapy , oncology , hematology , immunophenotyping , leukemia , bruton's tyrosine kinase , chemotherapy , immunology , flow cytometry , receptor , physics , tyrosine kinase , astrobiology